Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | F. Meric-Bernstam, N. Tannir, J. Harding, M. Voss, J. Mier, A. DeMichele, P. Munster, M. Patel, O. Iliopoulos, T. Owonikoko, S. Whiting, K. Orford, M. Bennett, R. Carvajal, R. McKay, A. Fan, M. Telli, J. Infante | ||||||||||||
Title | Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC) | ||||||||||||
|
|||||||||||||
URL | http://www.ecco-org.eu/Events/ENA2016/Searchable-Programme#anchorScpr | ||||||||||||
Abstract Text |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|